A detailed history of Beaumont Financial Partners, LLC transactions in Verastem, Inc. stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 48,000 shares of VSTM stock, worth $190,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,000
Previous 48,000 -0.0%
Holding current value
$190,080
Previous $56,000 26.79%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$2.54 - $4.07 $50,800 - $81,400
20,000 Added 71.43%
48,000 $148,000
Q2 2021

Aug 04, 2021

BUY
$2.57 - $4.85 $25,700 - $48,500
10,000 Added 55.56%
28,000 $113,000
Q1 2018

May 11, 2018

BUY
$2.92 - $3.81 $23,360 - $30,480
8,000 Added 80.0%
18,000 $54,000
Q2 2017

Aug 11, 2017

BUY
N/A
10,000
10,000 $22,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $832M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Beaumont Financial Partners, LLC Portfolio

Follow Beaumont Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.